The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.

CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...

CHICAGO--(BUSINESS WIRE)--Village Medical and The COPD Foundation today announced a webinar to support patients through Medicare Annual Enrollment Period (AEP). The free, educational event will focus ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

Patients who have comorbid COPD with heart failure and ischemic heart disease have increased health care resource use and higher mortality.

Pulmonary rehabilitation refers to a medical program that aims to help people with lung conditions breathe better and maintain a higher quality of life. There are many benefits to enrolling in these ...

Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by loss of lung elasticity, which leads to dysfunctional gaseous exchange. COPD is the third leading cause of ...

If you often feel short of breath when you talk, walk a short distance, or use the stairs, you might think it is just a ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need ...

People with schizophrenia are more likely to develop chronic obstructive pulmonary disease (COPD), suggesting a possible syndemic relationship between the two diseases, in addition to people not ...